Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Surgery versus radiotherapy: Long term outcomes of T1 glottic cancer.
Ferreira N, Netto E, Fonseca L, Fonseca J, Esteves S, Labareda M, Mota A, Pocinho R, Magalhães M, Santos F. Ferreira N, et al. Rep Pract Oncol Radiother. 2020 Nov-Dec;25(6):860-866. doi: 10.1016/j.rpor.2020.08.007. Epub 2020 Aug 19. Rep Pract Oncol Radiother. 2020. PMID: 32982591 Free PMC article.
Surgery vs. primary radiotherapy in early-stage oropharyngeal cancer.
Pedro C, Mira B, Silva P, Netto E, Pocinho R, Mota A, Labareda M, Magalhães M, Esteves S, Santos F. Pedro C, et al. Clin Transl Radiat Oncol. 2017 Dec 28;9:18-22. doi: 10.1016/j.ctro.2017.12.002. eCollection 2018 Feb. Clin Transl Radiat Oncol. 2017. PMID: 29594246 Free PMC article.
Feline leishmaniasis in an animal shelter in northeastern Brazil: Clinical aspects, coinfections, molecular detection, and serological study of a new recombinant protein.
Nascimento LFJ, Amado-Gomes AC, Dantas-Torres F, Santos FLN, Neres WS, Filho PES, Santos MT, Silva JRS, Resende CF, Dos Reis JKP, Jain S, Cunha JLR, Fujiwara RT, Dolabella SS. Nascimento LFJ, et al. Among authors: santos fln. Res Vet Sci. 2024 Apr 9;172:105256. doi: 10.1016/j.rvsc.2024.105256. Online ahead of print. Res Vet Sci. 2024. PMID: 38613921
Adjunctive pascolizumab in rifampicin-susceptible pulmonary tuberculosis: proof-of-concept, partially-randomised, double-blind, placebo-controlled, dose-escalation trial.
Paton NI, Gurumurthy M, Lu Q, Leek F, Kwan P, Koh HWL, Molton J, Mortera L, Naval S, Abu Bakar Z, Pang YK, Lum L, Lim TK, Cross GB, Lekurwale G, Choi H, Au V, Connolly J, Hibberd M, Green JA; Pascolizumab Tuberculosis Trial Team. Paton NI, et al. J Infect Dis. 2024 Mar 25:jiae104. doi: 10.1093/infdis/jiae104. Online ahead of print. J Infect Dis. 2024. PMID: 38527849
166 results